ASND Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 18536 min ago

@ $144.01

Wydano: 24 bal. 2024 @ 16:31

Zwrot: -6.95%

Poprzedni sygnał: bal. 22 - 20:18

Poprzedni sygnał: Sprzedaż

Zwrot: 0.54 %

Live Chart Being Loaded With Signals

Commentary (6 geg. 2024 @ 23:00):

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD)...

Stats
Dzisiejszy wolumen	438 186
Średni wolumen	333 446
Kapitalizacja rynkowa	7.59B
EPS	$-1.650 ( 2024-05-02 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-14.44
ATR14	$0.167 (0.12%)

Wolumen Korelacja

Długi: 0.09 (neutral)

Krótki: -0.89 (strong negative)

Signal:(42.088) Neutral

Ascendis Pharma A/S Korelacja

10 Najbardziej pozytywne korelacje
LMPX	0.937
ATHN	0.927
FXCO	0.923
FTNT	0.91
WYNN	0.908
ASRV	0.906
ZYXI	0.906
WABC	0.903
CYBR	0.902
ISEM	0.901

10 Najbardziej negatywne korelacje
BMEA	-0.955
TMTS	-0.938
CLXT	-0.936
ALDX	-0.925
SMFL	-0.913
RTPY	-0.904
COCO	-0.899
RIVE	-0.898
MOTNU	-0.887
POAI	-0.887

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ascendis Pharma A/S Korelacja - Waluta/Towar

0.29
( neutral )

0.22
( neutral )

0.10
( neutral )

0.18
( neutral )

0.12
( neutral )

-0.47
( neutral )

Ascendis Pharma A/S Finanse

Annual	2023
Przychody:	$266.72M
Zysk brutto:	$222.32M (83.36 %)
EPS:	$-8.55

FY	2023
Przychody:	$266.72M
Zysk brutto:	$222.32M (83.36 %)
EPS:	$-8.55

FY	2022
Przychody:	$51.17M
Zysk brutto:	$39.04M (76.28 %)
EPS:	$-10.40

FY	2021
Przychody:	$7.78M
Zysk brutto:	$4.26M (54.71 %)
EPS:	$-7.00

Financial Reports:

No articles found.

Ascendis Pharma A/S

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.